Latest Articles
Merck secures $700 million funding from Blackstone to develop cancer therapy - ETPharma.com
Merck secures $700 million funding from Blackstone to develop cancer therapy ETPharma.com
Published: Nov. 5, 2025, 12:32 p.m.
Merck secures $700 million funding from Blackstone to develop cancer therapy - ET Pharma
Merck secures $700 million funding from Blackstone to develop cancer therapy ET Pharma
Published: Nov. 5, 2025, 12:32 p.m.
Medical Link Between Hormone Therapy And Period Changes - Saralnama
Medical Link Between Hormone Therapy And Period Changes Saralnama
Published: Nov. 3, 2025, 10:46 p.m.
Frontline Considerations for Immunotherapy in Endometrial Cancer - OncLive
Frontline Considerations for Immunotherapy in Endometrial Cancer OncLive
Published: Nov. 3, 2025, 1:36 p.m.
Effects of miR-210-3p/SDF2 and miR-31-5p/FGF7 from hypoxic endometrial exosomes on UCB-MSC proliferation, migration, and differentiation - Stem Cell Research & Therapy
Effects of miR-210-3p/SDF2 and miR-31-5p/FGF7 from hypoxic endometrial exosomes on UCB-MSC proliferation, migration, and differentiation Stem Cell Research & Therapy
Published: Nov. 3, 2025, 10:18 a.m.
Mechanisms and applications of mesenchymal stem cell exosomes in enhancing fertility - Stem Cell Research & Therapy
Mechanisms and applications of mesenchymal stem cell exosomes in enhancing fertility Stem Cell Research & Therapy
Published: Oct. 28, 2025, 2:15 p.m.
Michelle Wise, MD, discusses levonorgestrel IUD offering effective endometrial protection during hormone therapy - Contemporary OB/GYN
Michelle Wise, MD, discusses levonorgestrel IUD offering effective endometrial protection during hormone therapy Contemporary OB/GYN
Published: Oct. 23, 2025, 8:33 p.m.
WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive
WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer OncLive
Published: Oct. 23, 2025, 6:03 p.m.
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer - Dana-Farber Cancer Institute
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer Dana-Farber Cancer Institute
Published: Oct. 21, 2025, 9 a.m.
Female Reproductive Digital Therapy Market Is Projected To Reach a Valuation of USD 12 Billion by 2035, Growing at a CAGR of 19.4% - industrytoday.co.uk
Female Reproductive Digital Therapy Market Is Projected To Reach a Valuation of USD 12 Billion by 2035, Growing at a CAGR of 19.4% industrytoday.co.uk
Published: Oct. 20, 2025, 10:14 a.m.
Link copied to clipboard!